Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

Clinical trial NCT06432036 · RECRUITING

Trial details

NCT number: NCT06432036
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage I Renal Cell Cancer Stage II Renal Cell Cancer

Start date: 2024-12-26
Primary completion: 2029-03-24
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.